Updates are available Correction dated 2024-02-12
Click to view Correction: https://doi.org/10.1186/s13034-024-00709-z
-
Authors
Astenvald, Rebecka
Frick, Matilda A.
Neufeld, Janina
Bölte, Sven
Isaksson, Johan
-
Funding
Funding for this research was provided by:
Uppsala Universitet
Vetenskapsrådet
VINNOVA
Svenska Forskningsrådet Formas
Hjärnfonden
Stockholm Brain Institute
Autism and Asperger Association Stockholm
Queen Silvia Jubilee Fund
Stiftelsen Solstickan
PRIMA Child and Adult Psychiatry
the Pediatric Research Foundation at Astrid Lindgren Children’s Hospital
the Swedish Foundation for Strategic Research
Stiftelsen Sven Jerrings Fond
Svenska Frimurarorden
Kempe-Carlgrenska Foundation
Stiftelsen Sunnerdahls Handikappfond
Jeanssons Stiftelser
AIMS-2-TRIALS (777394)
Uppsala University
- License Information
-
More Information
Article History
Received: 15 August 2022
Accepted: 15 November 2022
First Online: 28 November 2022
Change Date: 12 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13034-024-00709-z
Declarations
:
: This study was approved by the National Swedish Ethical Review Board and written and oral informed consent was obtained from all participants after the nature of the study procedure had been fully explained.
: All participants and their caregivers gave their written consent.
: The authors declare no conflict of interest related to this study. Bölte discloses that he has in the last 3 years acted as an author, consultant or lecturer for Medice and Roche. He receives royalties for textbooks and diagnostic tools from Hogrefe, Kohlhammer and UTB. Bölte is partner in SB Education/Psychological Consulting AB and NeuroSupportSolutions International AB.
